Stay updated on Durvalumab + Tremelumab in LS-SCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.

Latest updates to the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe record history now shows a new revision entry for the study (v3.7.0), indicating an updated version of the record compared to the prior revision.SummaryDifference0.1%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedNew revision entry v3.6.6 is added to the study record history, and the previous revision v3.6.5 is removed. This updates the page’s version history to reflect the latest release.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history and the previous revision v3.6.4 was removed, updating the visible version history of the page.SummaryDifference0.1%

- Check68 days agoChange DetectedA new release version (v3.6.4) was added to the page’s history. The previous version (v3.6.3) was removed, signaling a minor platform update reflected in the record history.SummaryDifference0.1%

- Check90 days agoChange DetectedThe history now shows a new system revision labeled v3.6.3, replacing the previous v3.6.2, indicating a platform update rather than modifications to the study record.SummaryDifference0.1%

- Check97 days agoChange DetectedThe record history now includes a new revision entry (v3.6.2) superseding the previous (v3.6.0). This indicates an update to the page history on ClinicalTrials.gov rather than a change to the study data.SummaryDifference0.1%

Stay in the know with updates to Durvalumab + Tremelumab in LS-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.